SureTrader
Interactive Brokers Advertisement
SureTrader
Home > Boards > US Listed > Biotechs >

Vascular Biogenics Ltd. (VBLT)

VBLT RSS Feed
Add VBLT Price Alert      Hide Sticky   Hide Intro
Moderator: gr8db8
Search This Board: 
Last Post: 6/28/2017 3:42:10 PM - Followers: 36 - Board type: Free - Posts Today: 1

Vascular Biogenics Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of treatments for cancer and immune-inflammatory diseases. Its clinical pipeline is based on two platform technologies that leverage the body’s natural physiologic and genetic regulatory elements. As of June 6, 2014, it has developed two programs based on these platforms an oncology program and an anti-inflammatory program. Its lead product candidate from its oncology program, VB-111, is a gene-based biologic that is initially developing for recurrent glioblastoma (rGBM), an aggressive form of brain cancer. The Company has also received orphan drug designation in both the United States and Europe. The Company’s oncology program is based on its Vascular Targeting System (VTS), platform technology, which utilizes genetically targeted therapy to destroy newly formed, or angiogenic, blood vessels. http://www.vblrx.com
VBLT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VBLT News: Report of Foreign Issuer (6-k) 06/22/2017 04:35:22 PM
VBLT News: Report of Foreign Issuer (6-k) 06/19/2017 04:34:03 PM
VBLT News: VBL Therapeutics Provides Update on Long-Term Survival in Phase 2 Trials of Patients with Multiple Tumor Types 06/19/2017 08:00:00 AM
VBLT News: VBL Therapeutics Announces Appointment of Dr. Corinne Epperly as U.S. Chief Operating Officer 06/15/2017 07:00:00 AM
VBLT News: VBL Therapeutics Awarded $2.5 Million Grant by the Israel Innovation Authority 06/08/2017 07:00:00 AM
PostSubject
#1071   This is an interesting list. 3 on the gr8db8 06/28/17 03:42:10 PM
#1070   It doesn't work that way. I believe dror davidal66 06/26/17 07:17:50 PM
#1069   wcopeland, This Stock will be an interim result Valueinvestor12 06/26/17 02:38:09 PM
#1068   another important note from last conference call during Valueinvestor12 06/26/17 09:24:44 AM
#1067   I m against combo against buyout and against Oren1976 06/25/17 11:13:39 PM
#1066   1. That would be great if they paired wcopeland 06/25/17 12:46:17 PM
#1065   Thanks for digging that up value! So, second wcopeland 06/25/17 11:28:17 AM
#1064   I think mid Aug- Early Sept the company Valueinvestor12 06/24/17 11:44:26 PM
#1063   Thanks for that, Valueinvestor12. I think the key gr8db8 06/24/17 05:03:05 PM
#1062   wcopeland ... good post! My thoughts are: gr8db8 06/24/17 04:50:18 PM
#1061   from last conference call Dr. Dror said: Valueinvestor12 06/24/17 04:14:02 PM
#1060   My guess: Second half of Q3, so mid-August wcopeland 06/24/17 10:56:27 AM
#1059   Your guess interim ? I think only q4 Oren1976 06/23/17 11:08:36 PM
#1058   They will choose the safest for lung cancer. Oren1976 06/22/17 07:34:20 PM
#1057   Dror has said several times now that they wcopeland 06/22/17 05:12:09 PM
#1056   Interesting development on an oncoprotein GT198, which these gr8db8 06/20/17 01:00:08 PM
#1055   More from the same session: gr8db8 06/19/17 06:20:42 PM
#1054   Insight on Epperly. Here's a snippet on her gr8db8 06/19/17 05:25:10 PM
#1053   Interesting the figure 50% achieved long term while Oren1976 06/19/17 01:03:14 PM
#1052   Intriguing indeed Like the risk/reward here mjw007 06/19/17 12:31:06 PM
#1051   The data is intriguing: "in all three indications gr8db8 06/19/17 12:19:58 PM
#1050   Clearly do not understand this market cap mjw007 06/19/17 09:34:55 AM
#1049   Also, news came out that Trump is going wcopeland 06/19/17 09:30:23 AM
#1048   1. Clearly market is loving the news so far. wcopeland 06/19/17 09:27:09 AM
#1047   Soon we know. They have a potential cure Oren1976 06/19/17 09:22:59 AM
#1046   How do you think the market reacts to mjw007 06/19/17 09:19:59 AM
#1045   Even this pr not clear and not fully Oren1976 06/19/17 09:18:17 AM
#1044   Imagine it was published at the asco ? Oren1976 06/19/17 09:14:35 AM
#1043   Maybe I am missing something But Wow! mjw007 06/19/17 09:12:09 AM
#1042   Any thoughts re news this morning? mjw007 06/19/17 09:04:57 AM
#1041   As always, thanks for the share gr8! I wcopeland 06/18/17 06:36:47 PM
#1040   Watch the 6/20, 11:45 am pt, webcast here: gr8db8 06/18/17 03:20:49 PM
#1039   The immune system knows how to deal with Oren1976 06/17/17 11:57:54 PM
#1038   On Tuesday the 20th june 2017 they will Oren1976 06/17/17 11:52:54 PM
#1037   I agree Exciting news for the VBLT longs mjw007 06/17/17 08:13:35 AM
#1036   Someone with her background (dual degree, Goldman, BMS) gr8db8 06/16/17 11:59:20 AM
#1035   Hi Oren, I called the investor relations in Valueinvestor12 06/16/17 01:15:29 AM
#1034   According to linkedin she still work at BM Oren1976 06/16/17 12:53:36 AM
#1033   Question about the COO hiring. Did vblt hired Valueinvestor12 06/15/17 04:10:48 PM
#1032   Question about the COO hiring. Did vblt hired Valueinvestor12 06/15/17 04:10:47 PM
#1031   Good analysis. I think it is very good davidal66 06/15/17 11:08:36 AM
#1030   Agreed, it is good news. Re-emphasizing gr8's second wcopeland 06/15/17 10:58:04 AM
#1029   It is a very significant announcement, imo. gr8db8 06/15/17 10:31:45 AM
#1028   Thoughts on new US Chief Operating Officer? Sounds positive mjw007 06/15/17 10:05:47 AM
#1027   I think the VB6XX series is still a wcopeland 06/15/17 04:37:05 AM
#1026   To paraphrase an old pray, he that watcheth davidal66 06/15/17 01:27:24 AM
#1025   The company already know their drug is an Oren1976 06/14/17 11:34:05 PM
#1024   Davidal are u sleeping ? Wake Up! Vb111 Oren1976 06/14/17 10:12:24 PM
#1023   Finally they start talking about vb111 to cure Oren1976 06/14/17 10:08:51 PM
#1022   Absolutely yes. This is a pure immunotherapy drug. Oren1976 06/14/17 10:07:45 PM
PostSubject